Pharmaceutical preparations for TNF inhibition

US6117895A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Helmut Wachtel · Berlin, DE
• Hermann Graf · Berlin, DE
• Herbert Schneider · Berlin, DE
• Daryl Faulds · Mill Valley, US
• H. Perez · Poway, US
• Harald Dinter · San Rafael, US

Key dates

• Filing date: Jul 18, 1996
• Grant date: Sep 12, 2000
• Expiry date: Jul 18, 2016

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula I ##STR1## are useful for treating TNF-mediated diseases.